Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 5320, USA.
J Thromb Haemost. 2010 Jul;8(7):1584-93. doi: 10.1111/j.1538-7836.2010.03883.x. Epub 2010 Apr 16.
Interaction of resting platelets with exposed components of the subendothelial matrix is an important early activating event that takes place at sites of vascular injury. Platelet responses to collagen are mediated by integrin alpha(2)beta(1) and the glycoprotein (GP)VI-Fc receptor (FcR) gamma-chain complex, whereas platelet activation by laminin is mediated by the related integrin, alpha(6)beta(1), and similarly requires signaling through GPVI-FcR gamma-chain.
Because the cell adhesion and signaling receptor PECAM-1 has previously been shown to dampen collagen-induced platelet activation, we sought to determine whether PECAM-1 might similarly regulate platelet activation by laminin.
METHODS/RESULTS: We found that PECAM-1 became tyrosine phosphorylated on its cytoplasmic immunoreceptor tyrosine-based inhibitory motifs following adhesion of either human or murine platelets to immobilized laminin. Whereas the presence or absence of PECAM-1 had no effect on either the rate or extent of platelet adhesion or spreading on laminin, PECAM-1 inhibited laminin-induced phosphorylation of GPVI-FcR gamma-chain immunoreceptor tyrosine-based activation motifs (ITAMs) and activation of its downstream effector, Syk kinase, and suppressed granule secretion.
Taken together, these data are consistent with previous findings in platelets and other blood and vascular cells that PECAM-1 functions by modulating ITAM-mediated signaling pathways that amplify cellular activation.
静止血小板与血管损伤部位的内皮下基质暴露成分相互作用是一个重要的早期激活事件。血小板对胶原的反应由整合素 α2β1 和糖蛋白(GP)VI-Fc 受体(FcR)γ链复合物介导,而血小板对层粘连蛋白的激活则由相关的整合素α6β1 介导,同样需要通过 GPVI-FcRγ链进行信号传递。
由于细胞黏附与信号受体 PECAM-1 先前已被证明可抑制胶原诱导的血小板激活,我们试图确定 PECAM-1 是否也可调节层粘连蛋白诱导的血小板激活。
方法/结果:我们发现,无论是人源还是鼠源血小板黏附于固定化层粘连蛋白后,PECAM-1 的细胞质免疫受体酪氨酸基抑制基序(ITIM)发生酪氨酸磷酸化。PECAM-1 的存在或缺失对血小板黏附或在层粘连蛋白上的扩展速度或程度没有影响,但可抑制层粘连蛋白诱导的 GPVI-FcRγ链免疫受体酪氨酸基激活基序(ITAM)的磷酸化和其下游效应物 Syk 激酶的激活,并抑制颗粒分泌。
这些数据与以前在血小板和其他血液和血管细胞中的发现一致,即 PECAM-1 通过调节 ITAM 介导的信号通路来放大细胞激活,从而发挥作用。